DMAC - Financial Reports List - DiaMedica Therapeutics Inc. - IntrinsicAlpha

DiaMedica Therapeutics Inc. DMAC

Healthcare - Biotechnology - NASDAQ - US

$ 4.05

-0.121 %

$ 174 M

Market Cap

-6.45

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	-49.62%	100.00%
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-53.07%	-43.96%
Annual Report	FY	10-K	2024-12-31	0.00%	-26.12%	-25.46%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-40.33%	33.27%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-14.34%	-18.92%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	2.30%	6.57%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-37.59%	-47.19%
Annual Report	FY	10-K	2023-12-31	0.00%	-41.72%	-51.90%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-46.16%	-229.73%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-33.32%	-40.93%

1